RT Journal Article
SR Electronic
T1 Toward noninvasive assessment of stroke risk in pediatric cerebrovascular disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.17.21267944
DO 10.1101/2021.12.17.21267944
A1 Horn, John D.
A1 Johnson, Michael J.
A1 Starosolski, Zbigniew
A1 Meoded, Avner
A1 Milewicz, Dianna M.
A1 Annapragada, Ananth
A1 Hossain, Shaolie S.
YR 2021
UL http://medrxiv.org/content/early/2021/12/21/2021.12.17.21267944.abstract
AB Background and Purpose Moyamoya disease (MMD) is a progressive steno-occlusive cerebrovascular disease leading to recurrent stroke. There is a lack of reliable biomarkers to identify unilateral stroke MMD patients who are likely to progress to bilateral disease and experience subsequent contralateral stroke(s). We hypothesized that local hemodynamics are predictive of future stroke and set out to noninvasively assess this stroke risk in pediatric MMD patients.Methods MR and X-ray angiography imaging were utilized to reconstruct patient-specific models of the circle of Willis of 6 pediatric MMD patients who had previous strokes, along with a control subject. Blood flow simulations were performed by using a Navier-Stokes solver within an isogeometric analysis framework. Vascular regions with a wall shear rate (WSR) above the coagulation limit (> 5000 s−1) were identified to have a higher probability of thrombus formation, potentially leading to ischemic stroke(s). Two metrics, namely, “critical WSR coverage” and “WSR score”, were derived to assess contralateral stroke risk and compared with clinical follow-up data.Results In two patients that suffered a contralateral stroke within two months of the primary stroke, critical WSR coverages exceeding 50% of vessel surface and WSR scores greater than 6x the control were present in multiple contralateral vessels. These metrics were not as conclusive in two additional patients with 3-to-5-year gaps between primary and contralateral strokes. However, a longitudinal study of one of these two cases, where a subsequent timepoint was analyzed, accurately predicted disease stabilization on the primary stroke side and an elevated contralateral stroke risk, thus indicating that post-stroke follow-up at regular intervals might be warranted for secondary stroke prevention.Conclusions WSR-based metrics could be predictive of future stroke risk after an initial stroke in MMD patients. In addition, more accurate predictions may be possible by performing patient-specific hemodynamic analysis at multiple timepoints during patient follow-up to monitor changes in the WSR-based metrics.Competing Interest StatementAA is a consultant to, and a founder and stockholder in, Alzeca Biosciences and a shareholder in Sensulin LLC. ZS is a stockholder in Alzeca Biosciences and a consultant for InContext.ia. All other authors declare that they have no conflict of interest.Funding StatementThis work was supported by NIH grant R03NS110442 to SSH, and an AHA Merit Award and the Olivia Petrera-Cohen Research Fund to DMM.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Baylor College of Medicine and affiliated hospitals gave ethical approval with a waiver of written authorization for consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsMMDMoyamoya DiseaseCoWCircle of WillisWSRWall Shear RateICAInternal Carotid ArteryMCAMiddle Cerebral ArteryACAAnterior Cerebral ArteryBABasilar ArteryCADComputer Aided DesignNURBSNon-Uniform Rational B-SplinesCWSRCCritical Wall Shear Rate Coverage